Benitec Biopharma Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for Benitec Biopharma stock have an average target of 27.67, with a low estimate of 22 and a high estimate of 32. The average target predicts an increase of 127.36% from the current stock price of 12.17.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$22	$27.67	$29	$32
Change	+80.77%	+127.36%	+138.29%	+162.94%

* Price targets were last updated on Mar 9, 2026.

Analyst Ratings

The average analyst rating for Benitec Biopharma stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	2	2	2	2	1	1
Buy	3	3	3	3	2	2
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	5	5	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $32	Strong Buy	Reiterates	$32	+162.94%	Mar 9, 2026
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $35 → $32	Strong Buy	Maintains	$35 → $32	+162.94%	Nov 24, 2025
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $28 → $35	Strong Buy	Maintains	$28 → $35	+187.59%	Nov 4, 2025
Silvan Tuerkcan Citizens	Citizens	Buy Maintains $20 → $22	Buy	Maintains	$20 → $22	+80.77%	Nov 4, 2025
Silvan Tuerkcan JMP Securities	JMP Securities	Buy Reiterates $20	Buy	Reiterates	$20	+64.34%	Sep 24, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

18.58M

EPS This Year

-1.15

from -1.05

EPS Next Year

-1.15

from -1.15

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Jun 30, 2021	Jun 30, 2022	Jun 30, 2023	Jun 30, 2024	Jun 30, 2025	Jun 30, 2026	Jun 30, 2027
Revenue	59.00K	73.00K	75.00K	-	-	-	18.58M
Revenue Growth	-42.16%	23.73%	2.74%	-	-	-	-
EPS	-54.94	-37.88	-14.12	-1.22	-1.05	-1.15	-1.15
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	8	8

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	114.8M
Avg	n/a	18.6M
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-1.02	0.08
Avg	-1.15	-1.15
Low	-1.46	-1.56

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.